期刊文献+

普拉克索治疗老年帕金森病伴发抑郁的临床疗效分析 被引量:4

Clinical curative effect analysis of pramipexole in the treatment of senile parkinson's disease with depression
下载PDF
导出
摘要 目的:研究普拉克索治疗老年帕金森病伴发抑郁的临床疗效。方法:收治老年帕金森病伴发抑郁患者100例,随机分为观察组与对照组各50例,对照组给予吡贝地尔缓释片治疗,观察组给予普拉克索治疗,对比两组患者的临床治疗效果。结果:治疗后,观察组患者的HAMD评分显著低于对照组;观察组的不良反应发生率显著低于对照组。结论:普拉克索治疗老年帕金森病伴发抑郁具有显著的临床疗效。 Objective:To study the clinical curative effect of pramipexole in the treatment of senile parkinson's disease with depression.Methods:100 patients with senile parkinson's disease with depression were selected.They were randomly divided into the observation group and the control group with 50 cases in each.The control group was given piribedil sustained-release tablets treatment,and the observation group was given pramipexole treatment.The clinical treatment effects were compared between groups.Results:After treatment,the HAMD score of the observation group was significantly lower than that of the control group,and the incidence of adverse reactions in the observation group was significantly lower than that of the control group.Conclusion:Pramipexole in the treatment of senile parkinson's disease with depression has a significant clinical curative effect.
作者 朱社华 Zhu Shehua(Department of Neurology,Heze Municiple Hospital of Shandong Province 274000)
出处 《中国社区医师》 2017年第10期74-74,76,共2页 Chinese Community Doctors
关键词 普拉克索 老年帕金森病 抑郁 Pramipexole Senile parkinson's disease Depression
  • 相关文献

参考文献6

二级参考文献74

  • 1吕荣祥.美多巴联合普拉克索治疗帕金森病的有效性及安全性研究[J].中国生化药物杂志,2014,34(3):153-155. 被引量:46
  • 2张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:617
  • 3Litvan I,Goldman JG,Trster AI,et al.Diagnostic criteria for mild cognitive impairment in Parkinson's disease:Movement Disorder Society Task Force guidelines[J].Movement Disorders,2012;27(3):349-56. 被引量:1
  • 4Lill CM,Roehr JT,Mc Queen MB,et al.Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics:The PDGene database[J].PLo S Genetics,2012;8(3):e1002548. 被引量:1
  • 5Muller T,Hellwig R,Muhlack S.Levodopa induces synthesis of nerve growth factor and growth hormone in patients with Parkinson disease[J].Clin Neuropharmacol,2011;34(3):101-3. 被引量:1
  • 6Schapira AH,Mc Dermott MP,Barone P,et al.Pramipexole in patients with early Parkinson's disease(PROUD):a randomised delayed-start trial[J].Lancet Neurol,2013;12(8):747-55. 被引量:1
  • 7Broen MP,Moonen AJ,Kuijf ML,et al.Factor analysis of the Hamilton Depression Rating Scale in Parkinson's disease[J].Parkinsonism Relat Dis,2015;21(2):142-6. 被引量:1
  • 8Kataoka H,Tanaka N,Saeki K,et al.Low frontal assessment battery score as a risk factor for falling in patients with Hoehn-Yahr StageⅢParkinson's disease:a 2-year prospective study[J].European Neurol,2013;71(3-4):187-92. 被引量:1
  • 9Hauser RA,Schapira AH,Barone P,et al.Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease[J].European J Neurol,2014;21(5):736-43. 被引量:1
  • 10Mizuno Y,Yamamoto M,Kuno S,et al.Efficacy and Safety of ExtendedVersus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa-Undertreated Parkinson Disease:A Double-Blind,Randomized Trial[J].Clin Neuropharmacol,2012;35(4):174-81. 被引量:1

共引文献180

同被引文献31

引证文献4

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部